Evaluation and characterisation of novel glucagon receptor antagonists for type 2 diabetes therapy
Glucagon receptor antagonism is becoming a key target area for type 2 diabetes treatment. This thesis evaluates the potential of novel peptide-based glucagon receptor analogues for type 2 diabetes therapy. Structural modifications of the well established glucagon analogue, desHis1Glu9-glucagon, was...
| Main Author: | |
|---|---|
| Published: |
University of Ulster
2012
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.588499 |